Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Asahi Kasei Pharma Corp.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Neurology (unspecified)
Indication DetailsTreat severe upper limb hemiplegia after stroke
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today